Clinical and histopathological features of advanced cutaneous squamous cell carcinoma with varying responses to cemiplimab
Cemiplimab is a safe and effective therapy, particularly in elderly patients. Well-differentiated tumors with low proliferative index, intratumoral inflammatory infiltrate, and tumor necrosis may predict better clinical response.
Authors
- Susanne Horn (ORCID: https://orcid.org/0000-0002-2902-0377)
- Lars‐Christian Horn (ORCID: https://orcid.org/0000-0002-9775-4858)
- Conrad Hempel (ORCID: https://orcid.org/0000-0001-9885-7165)
- Gabriela Vladimirova
- Mirjana Ziemer (ORCID: https://orcid.org/0000-0001-6488-1917)
Institutions
- Leipzig University (DE)
Publication Details
- Journal
- JDDG Journal der Deutschen Dermatologischen Gesellschaft
- Published
- 2024-11-03
- DOI
- https://doi.org/10.1111/ddg.15551
- Citations
- 2
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.77